Learn more →
Back to Expert Scholars
Immunotherapy / 免疫治疗Cancer Immunology

Mark J. Smyth

马克·史密斯

PhD

🏢QIMR Berghofer Medical Research Institute(QIMR伯格霍夫医学研究所)🌐Australia

Senior Principal Research Fellow; Head, Immunology in Cancer and Infection Laboratory高级首席研究员;癌症与感染免疫学实验室主任

120
h-index
2
Key Papers
5
Awards
3
Key Contributions

👥Biography 个人简介

Mark Smyth at QIMR Berghofer is Australia's foremost cancer immunologist, renowned for defining innate immune mechanisms of tumor control. His seminal studies on NK cells, TRAIL, and NKG2D ligands elucidated how innate immunity suppresses tumor development, and his preclinical work underpins multiple clinical checkpoint combination strategies.

Share:

🧪Research Fields 研究领域

NK Cell BiologyNK细胞生物学
TRAIL-Mediated Tumor KillingTRAIL介导的肿瘤杀伤
Innate Antitumor Immunity先天性抗肿瘤免疫
Checkpoint Blockade检查点阻断
Cancer Immunosurveillance癌症免疫监视

🎓Key Contributions 主要贡献

TRAIL and NK Cell-Mediated Tumor Immunosurveillance

Demonstrated that TRAIL and perforin expressed by NK cells and cytotoxic T lymphocytes are critical effectors of cancer immunosurveillance, providing mechanistic proof that the innate immune system continuously eliminates nascent tumors.

NKG2D and Innate Immune Recognition of Tumors

Showed that NKG2D on NK cells recognizes stress ligands upregulated on transformed cells, defining a key innate surveillance receptor whose engagement triggers tumor cell lysis and adaptive immune priming.

Combination Checkpoint and Innate Immunotherapy

Developed combinatorial strategies pairing anti-PD-1/CTLA-4 with NK-activating agents, demonstrating synergistic tumor rejection in preclinical models and informing multiple ongoing clinical trials.

Representative Works 代表性著作

[1]

Perforin and natural killer cells in cancer immunosurveillance

Immunity (2002)

Demonstrated that perforin-deficient mice develop tumors at higher rates, establishing perforin-dependent cytotoxicity as essential for innate cancer immunosurveillance.

[2]

TRAIL, NKG2D and anti-tumor immunity

Nature Reviews Immunology (2010)

Comprehensive review of innate immune effector mechanisms targeting tumors, covering TRAIL, NKG2D, and NK cell biology in the context of cancer immunosurveillance.

🏆Awards & Recognition 奖项与荣誉

🏆NHMRC Australia Fellow
🏆Ramaciotti Medal for Excellence in Biomedical Research
🏆Fellow of the Australian Academy of Science
🏆Cancer Council Queensland Research Award
🏆Inaugural ISIR-Bristol Myers Squibb Award in Cancer Immunology

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 马克·史密斯 的研究动态

Follow Mark J. Smyth's research updates

留下邮箱,当我们发布与 Mark J. Smyth(QIMR Berghofer Medical Research Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment